Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
Monday, June 8, 2020 - 10:20
in Health & Medicine
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the cancer drug acalabrutinib, a BTK inhibitor that is approved to treat several blood cancers, was associated with reduced respiratory distress […]